CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-Label, Randomized, Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Pegcetacoplan in the Treatment of Post-Transplant Recurrence of C3G or IC-MPGN

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04572854
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:29:05.452459+00:00
Published At: 2025-02-07T00:00:00+00:00
Record Updated At: 2026-04-21
Results Posted At: 2025-02-07
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["C3G", "IC-MPGN", "Renal Transplant", "Complement 3 Glomerulopathy", "Complement 3 Glomerulopathy (C3G)", "Dense Deposit Disease (DDD)", "Membranoproliferative Glomerulonephritis", "Membranoproliferative Glomerulonephritis (MPGN)", "Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)", "C3 Glomerulopathy", "C3 Glomerulonephritis", "Complement 3 Glomerulonephritis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-04-21"
protocolSection.identificationModule.nctId: "NCT04572854"
protocolSection.identificationModule.officialTitle: "An Open-Label, Randomized, Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of Pegcetacoplan in the Treatment of Post-Transplant Recurrence of C3G or IC-MPGN"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2025-02-07"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.